Literature DB >> 7870343

Molecular analysis of C3 allotypes in patients with systemic vasculitis.

J E Finn1, L Zhang, S Agrawal, D R Jayne, D B Oliveira, P W Mathieson.   

Abstract

The third component of complement (C3) exists in two main allotypic forms, C3S and C3F, distinguished at the DNA level by a single base change. An increased frequency of the rarer C3F allele has been reported in patients with the autoantibody nephritic factor and in several other autoimmune conditions such as rheumatoid arthritis and IgA nephropathy. Studies of the immunogenetic factors predisposing to the development of systemic vasculitis have produced conflicting results and no major genetic predisposing factors have been identified. We have studied the C3S/F polymorphism in 63 patients with systemic vasculitis using DNA allotyping by the amplification refractory mutation system, a modification of the polymerase chain reaction. The allele frequency in these patients was C3S 0.71, C3F 0.29 (expected C3S 0.8, C3F 0.19; chi-squared = 5.1, P < 0.025), with the average relative risk for the development of systemic vasculitis associated with the presence of a C3F allele being 2.6. Moreover, there was a marked excess of C3FF homozygotes (11/63, [17.5%], versus 4% expected: chi-squared = 9.5, p < 0.01). The average relative risk for the development of systemic vasculitis in C3F homozygotes was 5.1, indicating a gene dosage effect. These data indicate that the C3F allele is associated with a predisposition to the development of systemic vasculitis and that C3F homozygotes are at particularly high risk. This association is the strongest genetic factor reported so far for this group of diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870343

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

1.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 2.  Complement, age-related macular degeneration and a vision of the future.

Authors:  Karen M Gehrs; Jared R Jackson; Eric N Brown; Rando Allikmets; Gregory S Hageman
Journal:  Arch Ophthalmol       Date:  2010-03

3.  C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis.

Authors:  U Persson; L Truedsson; K W Westman; M Segelmark
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  The investigation of allele and genotype frequencies of human C3 (rs2230199) in south Iranian population.

Authors:  Najmeh Bazyar; Negar Azarpira; Saied Reza Khatami; Hamid Galehdari
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

5.  Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.

Authors:  Paul R Gigante; Ivan S Kotchetkov; Christopher P Kellner; Raqeeb Haque; Andrew F Ducruet; Brian Y Hwang; Robert A Solomon; Eric J Heyer; E Sander Connolly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-14       Impact factor: 10.154

6.  The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Authors:  D J Birmingham; F Irshaid; H N Nagaraja; X Zou; B P Tsao; H Wu; C Y Yu; L A Hebert; B H Rovin
Journal:  Lupus       Date:  2010-07-06       Impact factor: 2.911

7.  R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population.

Authors:  Jennyfer Zerbib; Florence Richard; Nathalie Puche; Nicolas Leveziel; Salomon Y Cohen; Jean-François Korobelnik; José Sahel; Arnold Munnich; Josseline Kaplan; Jean-Michel Rozet; Eric H Souied
Journal:  Mol Vis       Date:  2010-07-15       Impact factor: 2.367

Review 8.  The pulmonary physician in critical care * illustrative case 3: pulmonary vasculitis.

Authors:  M Griffith; S Brett
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

9.  Molecular characterization of the pig C3 gene and its association with complement activity.

Authors:  Klaus Wimmers; Supamit Mekchay; Karl Schellander; Siriluck Ponsuksili
Journal:  Immunogenetics       Date:  2003-01-09       Impact factor: 2.846

Review 10.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.